Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017857
Filing Date
2022-11-14
Accepted
2022-11-14 17:10:21
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20220930x10q.htm   iXBRL 10-Q 1265765
2 EX-31.1 fencf-20220930xex31d1.htm EX-31.1 13963
3 EX-31.2 fencf-20220930xex31d2.htm EX-31.2 18474
4 EX-32.1 fencf-20220930xex32d1.htm EX-32.1 9377
5 EX-99.1 fencf-20220930xex99d1.htm EX-99.1 163306
6 GRAPHIC fencf-20220930xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-22-017857.txt   5078457

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20220930.xsd EX-101.SCH 34923
8 EX-101.CAL fencf-20220930_cal.xml EX-101.CAL 30701
9 EX-101.DEF fencf-20220930_def.xml EX-101.DEF 160691
10 EX-101.LAB fencf-20220930_lab.xml EX-101.LAB 246233
11 EX-101.PRE fencf-20220930_pre.xml EX-101.PRE 244414
47 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20220930x10q_htm.xml XML 801521
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 221387504
SIC: 2836 Biological Products, (No Diagnostic Substances)